FORM 6-K

 

SECURITIES AND EXCHANGE COMMISSION
Washington D.C. 20549

 

Report of Foreign Issuer

 

Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934


For period ending May 22, 2008

GlaxoSmithKline plc
(Name of registrant)

 

980 Great West Road, Brentford, Middlesex, TW8 9GS
(Address of principal executive offices)


Indicate by check mark whether the registrant files or
will file annual reports under cover Form 20-F or Form 40-F


Form 20-F x Form 40-F
 --


Indicate by check mark whether the registrant by furnishing the
information contained in this Form is also thereby furnishing the
information to the Commission pursuant to Rule 12g3-2(b) under the
Securities Exchange Act of 1934.

Yes No x
  --

BLOCK LISTING SIX MONTHLY RETURN

Information provided on this form must be typed or printed electronically
 and provided to an 
ris
.

Date:
 
22
 May 2008

Name of 
applicant
:
GlaxoSmithKline plc
Name of scheme:
GlaxoSmithKline Share Option Plan - Ordinary Shares
Period of return:
From:
8
 November 2007
To:
30 April 2008
Balance of unallotted securities under scheme(s) from previous return:
2,490,262
Plus:  
The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
5,000,000
Less:  
Number of 
securities
 issued/allotted under scheme(s) during period (see LR3.5.7G):
1,
143,767
Equals:  
Balance under scheme(s) not yet issued/allotted at end of period:
6,346,495



Name of contact:
Victoria Whyte
Telephone number of contact:
020 8047 5000


 
 
BLOCK LISTING SIX MONTHLY RETURN

Information provided on this form must be typed or printed electronically
 and provided to an 
ris
.

Date:
 
22 May
 
2008

Name of 
applicant
:
GlaxoSmithKline plc
Name of scheme:
GlaxoSmithKline Share Option Plan - ADS
Period of return:
From:
8
 November 2007
To:
30 April 2008
Balance of unallotted securities under scheme(s) from previous return:
2,609,136
Plus:  
The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
10,000,000
Less:  
Number of 
securities
 issued/allotted under scheme(s) during period (see LR3.5.7G):
4,202,550
Equals:  
Balance under scheme(s) not yet issued/allotted at end of period:
8,406,586



Name of contact:
Victoria Whyte
Telephone number of contact:
020 8047 5000



 
 
BLOCK LISTING SIX MONTHLY RETURN

Information provided on this form must be typed or printed electronically
 and provided to an 
ris
.

Date:
 
22 May
 
2008

Name of 
applicant
:
GlaxoSmithKline plc
Name of scheme:
Glaxo Wellcome 
UK
 Share Option Scheme
Period of return:
From:
8
 November 2007
To:
30 April 2008
Balance of unallotted securities under scheme(s) from previous return:
5,119,750
Plus:  
The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
0
Less:  
Number of 
securities
 issued/allotted under scheme(s) during period (see LR3.5.7G):
0
Equals:  
Balance under scheme(s) not yet issued/allotted at end of period:
5,119,750



Name of contact:
Victoria Whyte
Telephone number of contact:
020 8047 5000


 
 
BLOCK LISTING SIX MONTHLY RETURN

Information provided on this form must be typed or printed electronically
 and provided to an 
ris
.

Date:
 
22 May
 
2008

Name of 
applicant
:
GlaxoSmithKline plc
Name of scheme:
Glaxo Wellcome International Share Option Scheme
Period of return:
From:
8
 November 2007
To:
30 April 2008
Balance of unallotted securities under scheme(s) from previous return:
13,267,156
Plus:  
The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
0
Less:  
Number of 
securities
 issued/allotted under scheme(s) during period (see LR3.5.7G):
0
Equals:  
Balance under scheme(s) not yet issued/allotted at end of period:
13,267,156



Name of contact:
Victoria Whyte
Telephone number of contact:
020 8047 5000


 
 
BLOCK LISTING SIX MONTHLY RETURN

Information provided on this form must be typed or printed electronically
 and provided to an 
ris
.

Date:
 
22 May
 
2008

Name of 
applicant
:
GlaxoSmithKline plc
Name of scheme:
Glaxo Group Limited Share Option Scheme
Period of return:
From:
8
 November 2007
To:
30 April 2008
Balance of unallotted securities under scheme(s) from previous return:
0
Plus:  
The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
0
Less:  
Number of 
securities
 issued/allotted under scheme(s) during period (see LR3.5.7G):
0
Equals:  
Balance under scheme(s) not yet issued/allotted at end of period:
0



Name of contact:
Victoria Whyte
Telephone number of contact:
020 8047 5000


 
 
BLOCK LISTING SIX MONTHLY RETURN

Information provided on this form must be typed or printed electronically
 and provided to an 
ris
.

Date:
 
22 May
 
2008

Name of 
applicant
:
GlaxoSmithKline plc
Name of scheme:
Glaxo Wellcome 1999 Share Option Plan
Period of return:
From:
8
 November 2007
To:
30 April 2008
Balance of unallotted securities under scheme(s) from previous return:
1,040,000
Plus:  
The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
0
Less:  
Number of 
securities
 issued/allotted under scheme(s) during period (see LR3.5.7G):
0
Equals:  
Balance under scheme(s) not yet issued/allotted at end of period:
1,040,000



Name of contact:
Victoria Whyte
Telephone number of contact:
020 8047 5000


 
 
BLOCK LISTING SIX MONTHLY RETURN

Information provided on this form must be typed or printed electronically
 and provided to an 
ris
.

Date:
 
22 May
 
2008

Name of 
applicant
:
GlaxoSmithKline plc
Name of scheme:
SmithKline Beecham 1989 Executive Share Option Plan - Approved - Ordinary Shares
Period of return:
From:
8
 November 2007
To:
30 April 2008
Balance of unallotted securities under scheme(s) from previous return:
204,242
Plus:  
The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
0
Less:  
Number of 
securities
 issued/allotted under scheme(s) during period (see LR3.5.7G):
40,636
Equals:  
Balance under scheme(s) not yet issued/allotted at end of period:
163,606



Name of contact:
Victoria Whyte
Telephone number of contact:
020 8047 5000


 
 
BLOCK LISTING SIX MONTHLY RETURN

Information provided on this form must be typed or printed electronically
 and provided to an 
ris
.

Date:
 
22 May
 
2008

Name of 
applicant
:
GlaxoSmithKline plc
Name of scheme:
SmithKline Beecham 1989 Executive Share Option Plan - Unapproved - ADS
Period of return:
From:
8
 November 2007
To:
30 April 2008
Balance of unallotted securities under scheme(s) from previous return:
275,420
Plus:  
The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
0
Less:  
Number of 
securities
 issued/allotted under scheme(s) during period (see LR3.5.7G):
0
Equals:  
Balance under scheme(s) not yet issued/allotted at end of period:
275,420



Name of contact:
Victoria Whyte
Telephone number of contact:
020 8047 5000


 
 
BLOCK LISTING SIX MONTHLY RETURN

Information provided on this form must be typed or printed electronically
 and provided to an 
ris
.

Date:
 
22 May
 
2008

Name of 
applicant
:
GlaxoSmithKline plc
Name of scheme:
SmithKline Beecham 1989 Executive Share Option Plan - Unapproved - Ordinary Shares
Period of return:
From:
8
 November 2007
To:
30 April 2008
Balance of unallotted securities under scheme(s) from previous return:
100,000
Plus:  
The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
0
Less:  
Number of 
securities
 issued/allotted under scheme(s) during period (see LR3.5.7G):
0
Equals:  
Balance under scheme(s) not yet issued/allotted at end of period:
100,000



Name of contact:
Victoria Whyte
Telephone number of contact:
020 8047 5000


 
 
BLOCK LISTING SIX MONTHLY RETURN

Information provided on this form must be typed or printed electronically
 and provided to an 
ris
.

Date:
 
22 May
 
2008

Name of 
applicant
:
GlaxoSmithKline plc
Name of scheme:
GlaxoSmithKline Savings Related Share Option Scheme
Period of return:
From:
8
 November 2007
To:
30 April 2008
Balance of unallotted securities under scheme(s) from previous return:
2,394,996
Plus:  
The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
5,000,000
Less:  
Number of 
securities
 issued/allotted under scheme(s) during period (see LR3.5.7G):
1,077,914
Equals:  
Balance under scheme(s) not yet issued/allotted at end of period:
6
,
317,082



Name of contact:
Victoria Whyte
Telephone number of contact:
020 8047 5000


 

SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised.

 

                                                             GlaxoSmithKline plc
                                                                    (Registrant)

Date: May 22, 2008                                                                                                              By: VICTORIA WHYTE
                                                                                                                                                                ------------------
                                                              Victoria Whyte
                                                 Authorised Signatory for and on
                                                   behalf of GlaxoSmithKline plc